Your browser doesn't support javascript.
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
Arbyn, Marc; Bruni, Laia; Kelly, Daniel; Basu, Partha; Poljak, Mario; Gultekin, Murat; Bergeron, Christine; Ritchie, David; Weiderpass, Elisabete.
  • Arbyn M; Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels B1050, Belgium. Electronic address: marc.arbyn@sciensano.be.
  • Bruni L; Consortium for Biomedical Research in Cancer Epidemiology Research Program, Catalan Institute of Oncology - IDIBELL, Barcelona, Spain.
  • Kelly D; Royal College of Nursing, School of Healthcare Sciences, University of Cardiff, Cardiff, UK.
  • Basu P; International Agency for Research on Cancer, Lyon, France.
  • Poljak M; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Gultekin M; Hacettepe University Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Ankara, Turkey.
  • Bergeron C; Laboratoire Cerba, Cergy Pontoise France, Paris, France.
  • Ritchie D; Association of European Cancer Leagues, Brussels, Belgium.
  • Weiderpass E; International Agency for Research on Cancer, Lyon, France.
Lancet Public Health ; 5(8): e425, 2020 08.
Article in English | MEDLINE | ID: covidwho-641267

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Uterine Cervical Neoplasms / Coronavirus Infections / Pandemics Limits: Female / Humans Country/Region as subject: Europa Language: English Journal: Lancet Public Health Year: 2020 Document Type: Article

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Uterine Cervical Neoplasms / Coronavirus Infections / Pandemics Limits: Female / Humans Country/Region as subject: Europa Language: English Journal: Lancet Public Health Year: 2020 Document Type: Article